Concurrent chemoradiotherapy with docetaxel for T2 laryngeal carcinoma

Tokai Journal of Experimental and Clinical Medicine

Volumn 33, Issue 3, 2008, Pages 130-134

  Okami, Kenji ^a   Hamano, Takahide ^a   Takeo, Teruhisa ^a   Sakai, Akihiro ^a   Onuki, Junichi ^a   Odagiri, Kyoko ^a   Tamai, Yoshifumi ^a   Ohizumi, Yukio ^a   Iida, Masahiro ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Laryngeal preservation; Outpatient; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; TAXOID;

AGED; ARTICLE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LARYNX TUMOR; MALE; MULTIMODALITY CANCER THERAPY; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAXOIDS; TREATMENT OUTCOME;

EID: 66349137869     PISSN: 03850005     EISSN: 21852243     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Jones AS, Fish B, Fenton JE, Husband DJ. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation? Head Neck 2004; 26: 127-135.
2. Hinerman RW, Mendenhall WM, Amdur RJ, Villaret DB, Robbins KT. Early laryngeal cancer. Curr Treat Options Oncol 2002; 3: 3-9.
3. Inoue T, Inoue T, Ikeda H, Teshima T, Yamazaki H, Murayama S, et al. Comparison of early glottic and supraglottic carci- noma treated with conventional fractionation of radiotherapy. Strahlenther Onkol 1993; 169: 584-589.
4. Hinerman RW, Mendenhall WM, Amdur RJ, Stringer SP, Villaret DB, Robbins KT. Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection. Head Neck 2002; 24: 456-467.
5. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. T1- T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 2001; 19: 4029-4036.
6. Murakami R, Nishimura R, Baba Y, Furusawa M, Ogata N, Yumoto E, et al. Prognostic factors of glottic carcinomas treated with radiation therapy: value of the adjacent sign on radiologi- cal examinations in the sixth edition of the UICC TNM staging system. Int J Radiat Oncol Biol Phys 2005; 61: 471-475.
7. Sakata K, Oouchi A, Nagakura H, Akiba H, Tamakawa M, Koito K, et al. Accelerated radiotherapy for T1, 2 glottic carci- noma: analysis of results with KI-67 index. Int J Radiat Oncol Biol Phys 2000; 47: 81-88.
8. Nagahashi T, Fukuda S, Homma A, Yagi K, Furuta Y, Inuyama Y. Concurrent chemotherapy and radiotherapy as initial treat- ment for stage II supraglottic squamous cell carcinoma. Auris Nasus Larynx 2001; 28: S95-S98.
9. Ringel I, Horwitz SB. Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst 1991; 83: 288-291.
10. Dreyfuss AI, Clark JR, Norris CM, Rossi RM, Lucarini JW, Busse PM, Poulin MD, Thornhill L, Costello R, Posner MR. Docetaxel: an active drug for squamous cell carcinoma of the head and neck. J Clin Oncol 1996; 14: 1672-1678.
11. Catimel G, Verweij J, Mattijssen V, Hanauske A, Piccart M, Wanders J, et al. Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group. Ann Oncol. 1994; 5: 533-537.
12. Fujii M, Tsukuda M, Satake B, Kubota A, Kida A, Kohno N, Okami K, Inuyama Y. Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck. Int J Clin Oncol 2004; 9:107-112.
13. Wang CC, Nakfoor BM, Spiro IJ, Martins P. Role of accelerated fractionated irradiation for supraglottic carcinoma: assessment of results. Cancer J Sci Am 1997; 3: 88-91.
14. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal can- cer. N Engl J Med 1991; 324: 1685-1690.
15. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2004; 349: 2091-2098.
16. Weinstein GS, Myers EN, Shapshay SM, Weber R. Nonsurgical treatment of laryngeal cancer. N Engl J Med 2004; 350: 1049-1053.
17. Laccourreye O, Diaz EM Jr, Bassot V, Muscatello L, Garcia D, Brasnu D. A multimodal strategy for the treatment of patients with T2 invasive squamous cell carcinoma of the glottis. Cancer 1999; 85: 40-46.
18. Le QT, Fu KK, Kroll S, Ryu JK, Quivey JM, Meyler TS, et al. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys 1997; 39: 115-126.
19. Burke LS, Greven KM, McGuirt WT, Case D, Hoen HM, Raben